CClinicalTrials.gg
CompletedNCT02133209Updated Aug 8, 2018

MRI Outcomes of Mindfulness Meditation for Migraine

An interventional study of Mindfulness Based Stress Reduction and Stress Management for Headaches in Migraine, sponsored by Johns Hopkins University. Completed at 2 sites in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-08-08.

Sponsored by Johns Hopkins University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
98
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

112 migraine subjects will be initially randomly assigned to Mindfulness-Based Stress Reduction (MBSR) or a Stress Management for Headache group (SMH). Outcomes, including headache frequency and impact and brain activity, will be assessed at baseline, prior to intervention, and at 3-, 6-, and 12-months.

Read the detailed description

Subjects in the MBSR group undergo a standardized 8-week MBSR course plus an additional 4 sessions over another 8 weeks that further emphasize and train subjects on MBSR concepts and skills. The SMH group will have 12 sessions spread out in a similar fashion to MBSR. Clinical outcomes are compared between groups at 3, 6, and 12 months to assess efficacy of MBSR. MRI scans are performed at baseline, 3 months, and 6 months changes in MRI metrics after MBSR and changes in MRI metrics associated with long-term MBSR practice. 30 healthy controls will also undergo MRI scanning to determine abnormal brain activity and structure in migraineurs compared to healthy controls across the 6 month period of observation.

02

Conditions studied

  • Migraine

Browse trials for

Keywords

  • migraine
  • headache
  • meditation
  • mindfulness based stress reduction
  • MBSR
03

In context

Migraine Disorders

1,528 studies on the registry are indexed under Migraine Disorders; 299 are open to participants now.

This study's enrollment of 98 is above the median of 80 across 1,175 interventional studies indexed under Migraine Disorders.

Browse Migraine Disorders studies →

Lead sponsor

Johns Hopkins University is the lead sponsor of 1,783 studies on the registry; 313 are open to participants now.

Of its 203 completed or terminated interventional studies of FDA-regulated products, 140 (69%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Are between 18 and 65 years of age
  • Report between 4 and 14 headaches over 28 days
  • Have a history of migraines lasting at least 1 year
  • Are not currently using opioid ("narcotic") pain medication

Exclusion criteria

Exclusion Criteria

  • Are unable to undergo MRI
  • Pregnant, lactating, or planning to become pregnant
  • Current use of opioid medications

Inclusion Criteria for Healthy Volunteers (same exclusion criteria)

  • Are between 18 and 65 years of age
  • Free of any acute or chronic pain condition and reports no history of migraines
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
98 participants (actual)

Study arms

  • Active comparator
    Stress Management for Headaches

    This intervention involves a standardized stress management for headaches (SMH) group intervention that focuses on stress and general stress management skills for managing migraine headaches.

    Behavioral: Stress Management for Headaches

  • Active comparator
    Mindfulness Based Stress Reduction

    Intervention involves a standardized mindfulness-based stress reduction (MBSR) group intervention following the guidelines originally conceived and developed by the Center for Mindfulness in Medicine, Health Care and Society at the University of Massachusetts. The intervention also included an extended period of training in addition to the usual 8 weeks.

    Behavioral: Mindfulness Based Stress Reduction

Interventions

  • BehavioralMindfulness Based Stress Reduction

    Mindfulness Based Stress Reduction (MBSR) involves focused attention while practicing moment-to-moment nonjudgmental awareness of the self with the goal of achieving emotional balance and clarity of thought. There will be 8 weekly sessions and a half day retreat followed by 4 bi-weekly sessions over a period of 4 months.

  • BehavioralStress Management for Headaches

    Intervention involves a standardized stress management for headaches (SMH) group intervention that focuses on stress and general stress management skills, headache symptoms and their management, sleep hygiene, and healthy eating. There will be 8 weekly sessions followed by 4 bi-weekly sessions over a period of 4 months.

06

What researchers measure

Primary outcomes

  1. Change in headache frequency and impact

    Headache days per 28 days and headache-related disability (HIT-6)

    Time frame: Baseline, 3, 6, and 12 months

  2. Change in gray matter volume

    Gray matter volume in the insula, dorsolateral prefrontal cortex, and cingulate

    Time frame: Baseline, 3, and 6 months

  3. Change in Brain Function

    Overall activation of the dorsolateral prefrontal cortex and the task-positive cognitive network, and resting state connectivity to the insula

    Time frame: Baseline, 3, and 6 months

Secondary outcomes

  1. Change in headache intensity

    Change in headache intensity

    Time frame: Baseline, 3, 6, and 12 months

  2. Change in Brain Structure

    Gray matter volume and white matter tracts across the whole brain

    Time frame: Baseline, 3, and 6 months

  3. Change in Whole Brain Function

    Cognitive-related activity, pain-related activity, and resting state across the whole brain

    Time frame: Baseline, 3, and 6 months

07

Study locations

2 sites
  • University of Maryland School of Dentistry
    Baltimore, Maryland 21201, United States
  • Johns Hopkins University, Bayview Medical Campus
    Baltimore, Maryland 21224, United States
08

References and documents

Publications

  • Burrowes SAB, Goloubeva O, Keaser ML, Haythornthwaite JA, Seminowicz DA. Differences in gray matter volume in episodic migraine patients with and without prior diagnosis or clinical care: a cross-sectional study. J Headache Pain. 2021 Oct 23;22(1):127. doi: 10.1186/s10194-021-01340-5. PubMed 34688253 ↗
  • Burrowes SAB, Goloubeva O, Stafford K, McArdle PF, Goyal M, Peterlin BL, Haythornthwaite JA, Seminowicz DA. Enhanced mindfulness-based stress reduction in episodic migraine-effects on sleep quality, anxiety, stress, and depression: a secondary analysis of a randomized clinical trial. Pain. 2022 Mar 1;163(3):436-444. doi: 10.1097/j.pain.0000000000002372. Erratum In: Pain. 2023 Feb 01;164(2):e120. doi: 10.1097/j.pain.0000000000002843. PubMed 34407032 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 8, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02133209
Lead sponsor
Johns Hopkins University
Collaborators
National Center for Complementary and Integrative Health (NCCIH), University of Maryland
Responsible party
Sponsor
First posted
May 7, 2014
Start date
May 2014
Primary completion
Mar 2018
Completion
Mar 2018
Last update
Aug 8, 2018

Study contacts

Jennifer A Haythornthwaite, Ph.D.
study director · Johns Hopkins University
David Seminowicz, Ph.D.
principal investigator · University of Maryland

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion